Immune therapy scores big win against lung cancer in study

CHICAGO (AP) — New research suggests that many more lung cancer patients may benefit from treatments that boost the immune system, which have scored some of their biggest wins until now in less common forms of the disease. One study found using one of these drugs — Merck’s Keytruda (kee-TROO-dah) — with usual chemotherapy...